164
Views
14
CrossRef citations to date
0
Altmetric
Review

The link between VLA-4 and JC virus reactivation

&
Pages 63-72 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Fabio Salvatore Macaluso, Sara Renna, Ambrogio Orlando & Mario Cottone. (2017) The biologics of ulcerative colitis. Expert Opinion on Biological Therapy 17:2, pages 175-184.
Read now
Jill MV Petkau & Bertus Eksteen. (2016) Selective biologics for ulcerative colitis and Crohn’s disease – clinical utility of vedolizumab. Biologics: Targets and Therapy 10, pages 33-52.
Read now
Tej Pratap Singh, Chang Hoon Lee & Joshua M Farber. (2013) Chemokine receptors in psoriasis. Expert Opinion on Therapeutic Targets 17:12, pages 1405-1422.
Read now

Articles from other publishers (11)

Amirreza Azimi, Sara Hanaei, Mohammad Ali Sahraian, Mehdi Mohammadifar, Sreeram V. Ramagopalan & Mahsa Ghajarzadeh. (2020) Incidence of seroconversion and sero-reversion in patients with multiple sclerosis (MS) who had been treated with natalizumab: A systematic review and meta-analysis. Journal of Clinical Neuroscience 71, pages 129-134.
Crossref
Mohamed Elfeky, Daisuke Kamimura, Yasunobu Arima, Masaaki Murakami & Lawrence Steinman. (2017) Targeting molecules involved in immune cell trafficking to the central nervous system for therapy in multiple sclerosis. Clinical and Experimental Neuroimmunology 8:3, pages 183-191.
Crossref
Stephan Halle, Olga Halle & Reinhold Förster. (2017) Mechanisms and Dynamics of T Cell-Mediated Cytotoxicity In Vivo. Trends in Immunology 38:6, pages 432-443.
Crossref
Deborah J. Fowell. 2016. Encyclopedia of Immunobiology. Encyclopedia of Immunobiology 336 343 .
Sarbjit Singh, Gajulapati Veeraswamy, Deepak Bhattarai, Ja-Il Goo, Kyeong Lee & Yongseok Choi. (2015) Recent Advances in the Development of Pharmacologically Active Compounds that Contain a Benzoxazole Scaffold. Asian Journal of Organic Chemistry 4:12, pages 1338-1361.
Crossref
Martin Schlesinger & Gerd Bendas. (2015) Vascular cell adhesion molecule-1 (VCAM-1)-An increasing insight into its role in tumorigenicity and metastasis. International Journal of Cancer 136:11, pages 2504-2514.
Crossref
Olivier Outteryck, Hélène Zéphir, Julia Salleron, Jean-Claude Ongagna, Ana Etxeberria, Nicolas Collongues, Arnaud Lacour, Marie-Céline Fleury, Frédéric Blanc, Marianne Giroux, Jérôme de Seze & Patrick Vermersch. (2013) JC-virus seroconversion in multiple sclerosis patients receiving natalizumab. Multiple Sclerosis Journal 20:7, pages 822-829.
Crossref
Kathleen Costello. (2013) Multiple Sclerosis Research. Journal of Neuroscience Nursing 45:6, pages S14-S23.
Crossref
Clemens Warnke, Michael Pawlita, Thomas Dehmel, Anita Posevitz-Fejfar, Hans-Peter Hartung, Heinz Wiendl, Bernd C Kieseier & Ortwin Adams. (2013) An assay to quantify species-specific anti-JC virus antibody levels in MS patients. Multiple Sclerosis Journal 19:9, pages 1137-1144.
Crossref
Guglielmo Manenti, Simone Altobelli, Marco Nezzo, Marco Antonicoli, Erald Vasili, Luca Neroni, Roberto Floris & Giovanni Simonetti. (2013) Early Magnetic Resonance Detection of Natalizumab-Related Progressive Multifocal Leukoencephalopathy in a Patient with Multiple Sclerosis. Case Reports in Radiology 2013, pages 1-8.
Crossref
Daniel Ontaneda & Daniela Di Capua. (2012) Benefits versus risks of latest therapies in multiple sclerosis: a perspective review . Therapeutic Advances in Drug Safety 3:6, pages 291-303.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.